COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00128011
Recruitment Status : Completed
First Posted : August 9, 2005
Last Update Posted : November 10, 2006
National Institute of Hygiene and Epidemiology, Vietnam
Göteborg University
Information provided by:
International Vaccine Institute